Open AccessPassive dual immunization against tumour necrosis factor‐alpha (TNF‐α) and IL‐1β maximally ameliorates acute aminonucleoside nephrosis
Author(s) -
MARTÍN A.,
MOLINA A.,
BRICIO T.,
MAMPASO F.
Publication year - 1995
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.1995.tb05546.x
Subject(s) - nephrosis , tumor necrosis factor alpha , medicine , immunology , nephritis , proteinuria , cytokine , beta (programming language) , alpha (finance) , dexamethasone , in vivo , interleukin 6 , endocrinology , antibody , biology , kidney , construct validity , nursing , microbiology and biotechnology , computer science , patient satisfaction , programming language
SUMMARY Rats receiving a single dose (10mg/100g) of aminonucleoside of puromycin (PAN) develop heavy proteinuria and acute interstitial nephritis (AIN). Whole isolated glomeruli from rats injected with PAN secreted both TNF‐α and IL‐1β cytokines. TNF‐α secretion was first and maximally detected on day 3, whereas IL‐β activity was found on day 7, when rats were heavily proteinuric and AIN developed. In vivo treatment with either anti‐TNF‐α or anti‐IL‐1β antibodies produced a drastic and simultaneous reduction in both levels of proteinuria and intensity of interstitial cell infiltrate. These effects improved when both antibodies were administered together. Our studies demonstrate the effectiveness of immunosuppressive therapy against these two cytokines in rats with PAN‐induced nephrosis.